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ABSTRACT 
Warts are benign epithelial hyperplasia manifesting mostly due to infection 
with human papilloma virus (HPV). The condition may affect the patient with 
or without pain, itching etc. Wart can became a stressful cosmetic problem. 
The references of Charmakeela in Kshudraroga adhikara in the Ayurvedic 
classics have a very close clinical proximity with warts. Kshara is one among 
the treatment choice for Charmakeela and used in Pratisaraneeya kshara form. 
Subcutaneous intralesional injection is one among the upgraded modalities of 
Pratisaraneeya ksharakarma. Kshara used as Ksharodhaka for this procedure. 
A 24 years old female patient with a common wart over the thumb visited the 
Salyatantra OPD, Govt. Ayurveda College Hospital Tripuithura in June 2019. 
The lesion was painless and without itching and was developed within a 
period of one month. The patient was undertaken for subcutaneous 
intralesional injection of Aragwadha ksharodhaka following proper lab 
investigations. The patient did not developed any adverse reactions or pain 
during the procedure. It was observed that, the wart shed off within a period 
of 7 days. There was no visible ulceration over the site of wart and healing 
happened leaving a minimum scar. Also there was visible healthy skin 
formation. 
 
INTRODUCTION 
Warts being a very common skin 
manifestation results from hyperkeratinised lesion 
over the skin. It cause cosmetic distress and 
pressure in affected subjects since antiquity. This is 
considered as a benign growth affecting basal layer 
of skin epidermis[1]. The most common cause is 
infection with human papilloma virus (HPV). A pre-
existing micro-trauma of the skin or epidermal 
barrier at any part of the body can gives the virus 
entry[2]. 
The conventional system of medicine gives 
majority of the treatment based on destruction of 
keratinocytes irrespective of HPV involvement. 
Cryotherapy, keratolytic ointments, lasers, 
curettage and electro desiccation are used for this[3]. 
Ayurvedic classics give references of Charmakeela 
which can be correlate with warts. Charmakeela 
appears as Keelavat mamsangura (nail like 
projections of fleshy origin) in the skin due to 
vitiation of Vyanavayu and Kapha[4]. This is detailed 
as an Adhimaamasa vikara (disease due to excess 
muscle tissue) along with description of Arshas 
(haemorrhoids) and enumerated as one among the 
Kshudraroga (diseases of minor category)[5]. 
Ayurveda gives management of Charmakeela with 
oral medications, topical use of Kshara (ash of herbs 
with caustic property) Agni (thermal cautery) and 
Shastra karma (surgery) [6]. Kshara is of two type; 
Paneeya (internal administration) and 
Pratisaraneeya (external application)[7]. This is 
considers as the best treatment among all surgical 
and parasurgical procedures[8]. As a disease 
affecting the skin, the drug Aragwadha (Cassia 
fistula Linn.) with proven clinical effects in skin 
diseases used for Ksharakarma in the case. The 
drug is one among the twenty four drugs of 
Ksharagana (group of drugs used for Kshara 
preparation) detailed by Acharya Susrutha. 
WHO point out that 70-80% of world 
population depends on nonconventional medicine 
or herbal preparations for treatment purposes. It 
shows the necessity of advancement and validation 
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of Ayurvedic treatment modality. [9] Introduction of 
nasal sprays and herbal injectables in Ayurvedic 
medicine are examples for this. The subcutaneous 
intralesional injection is one of the modified 
Pratisaraneeya kshara karma (external application 
of herbal ash with caustic property). The caustic 
properties of Kshara may works as a sclerosant 
agent locally with tissue necrosis resulting in falling 
off of the unwanted tissues in the wart. This may 
give healthy epithelialisation without an open 
wound and minimum scar.  
Considering the clinical presentations of 
Charmakeela, Aragwadha teekshana kshara (caustic 
alkali of strong potency prepared from the drug 
cassia fistula Linn.) was used for the case study 
here. The patient was treated with subcutaneous 
intralesional injection of Aragwadha teekshna 
kshara in Ksharodhaka (Kshara liquid) form. 
Case report 
A 24 years old female patient presented 
with single painless common warts on the left 
thumb above the metacarpo-phalangeal crease 
visited the Salyatantra OPD, Govt. Ayurveda College 
Hospital Tripunithura in June 2019. She was a 
college student and had discomfort and cosmetical 
distress with the wart. According to the patient the 
lesion noted as a point of abnormal hardness before 
one month. Later she noted an increase in its size 
with a dark brown colour without itching. There 
was no relevant family history. The patient also had 
no history of any associated comorbidities and was 
advised to undergo lab investigations, this was 
found within normal limits. 
Table 1: Clinical features of wart lesion observed on 11.06.2019 
Wart characteristic Observation  
Site of wart Left thumb above the MCP crease 
Number 1 
Basal diameter 0.3mm *0.2mm 
Colour Dark brown 
Level  Elevated from skin level. 
Aspect  Rough and lobed 
Border  sharp 
Border erythema  Absent 
Table 2: Results of laboratory investigation done on 12.06.2019  
Investigation Value 
Blood Sugar 
FBS 98 mg% 
PPBS 110 mg% 
Lipid Profile 
Total cholesterol 180 mg%  
S. Triglycerides 80 mg% 
Serum creatinine 0.7 mg% 
Haematology 
Haemoglobin 13 gm% 
Total WBC count 8200 cells/cumm. 
Differential count  
a. Polymorphs 52% 
b. Eosinophils 08% 
c. Lymphocytes  35% 
ESR 10 mm/hr. 
Platelet count  3.0 lakhs/cells /cu.mm 
AEC 480 cells/cu.mm 
Bleeding time 2 min. 15 sec. 
Clotting time 4 min. 30 sec. 
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Preparation of Aragwadhateekshna kshara [10] 
Medicine prepared as per classical reference 
of Susrutha samhitha. The dried pieces of 
Aragwadha (Cassia fistula Linn.) bark 10 kg burnt to 
ash along with 100 gm Sudhasarkara (drug with 
calcium content) after cooling, the ash of 
Aragwadha and Sudhasarkara is collected 
separately. Water is added in a ratio of 1:6 into the 
Kshara of Aragwadha. i.e., 1 part Aragwadhakshara 
with 6 part water and is mixed well. The 
supernatant solution is then strained through a 
piece of clean cotton cloth for 21 times till a clear 
liquid is obtained. This liquid is taken in an iron 
vessel and heated over a moderate fire. When this 
liquid become clear, red in colour, sharp and slimy, 
add 100 mg of Bhasma (ash) of Sudhasarkara into it, 
later the powder of Langali (Gloriosa superba), 
Chitraka (Plumbago zeylanica), Vaca (Acorus 
calamus) are added and is cooked again till it 
reaches a stage of powder. This substance known as 
Aragwadha teekshna kshara (potent alkali 
preparation of Cassia fistula Linn). It is stored in air 
tight sterile container. 
Subcutaneous intralesional injection procedure 
(Done on 12.06.2019) 
Written consent was obtained from the 
patient prior to the procedure. The patient is made 
to a comfortable posture. All aseptic precautions 
were taken. The stored 500 mg of Aragwadha 
teekshna kshara was taken and mixed with 2ml 
distilled water and Ksharodhaka (liquid form of 
Kshara) made. 1ml. of this Ksharodhaka drawn in to 
a 2 ml. disposable syringe with a number 24 gauge 
needle.  A test dose of 0.1 ml Ksharodhaka taken 
near the lesion one hour before procedure. As the 
patient observed safe for further procedure, 
Injection was given slowly underneath the warts at 
multiple sites around the lesion by pointing the 
needle bevel upwards. 
Figure 1: Aragwadhateekshnakshara 
 
Figure 2: Preparation of Ksharodhaka for injection 
 
Follow up advises 
The patient was advised to avoid water 
contact for 3 hours immediately after injection 
procedure and follow vegetarian diet for next one 
week without curd and cold food items. She was 
also advised to avoid spice, salt and sour in excess.   
Observations and Result 
During the subcutaneous intralesional 
injection of Aragwadhaksharodhaka (on 12.06. 
2019), the patient complained of mild pain and 
burning at the site for a short period of less than 2 
minutes. The local wart site was observed for 
change in the basal diameter, nature of shedding of 
hyperkeratinised tissues and scar on alternative 
days after the injection procedure. Pain, burning 
sensation, itching and hardness at the wart site was 
observed as subjective features of the patient. On 
the next day (13.06.2019), the wart turned soft, 
darker and a negligible pain was noted by the 
patient. On gradual observation, the wart found to 
shed the hyperkeratinised tissues off. By 
18.06.2019, there was complete shedding of the 
raised tissue (within a period of 7 days) leaving no 
evidence of wound. Basal diameter, which was 
taken as the area covered by the hyper granulated 
and hyperkeratinised tissues, observed to reduce to 
a state of absent by the end of 12 days after 
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injection. The scar observed to appear from 4th day 
(16.06.2019) onwards following injection. This was 
with minimum fibrous tissue and the local site was 
without any hardness. The wart site presented with 
normal skin by the end of 28.06.2019 that is, a total 
of seventeen days after the injection procedure. 
There was no pain, itching, burning sensation or 
other skin manifestations during any of these 
periods. The wart site also gained completely 
normal touch sensation and almost healthy skin 
around. 
Figure 3: Wart during injection procedure 
12.06.2019 
 
Wart immediately after 
injection 
14.06.2019 
 
2 days after injection 
16.06.2019 
 
4 days after injection 
18.06.2019 
 
6 days after injection 
23.06.2019 
 
12 days after injection 
28.06.2019 
 
17 days after injection 
Table 3: Observations of wart done during treatment 
Observational 
features 
Days of observations with findings 
 
Basal 
diameter 
12.06.2019 14.06.2019 16.06.2019 18.06.2019 23.06.2019 28.06.2019 
No change 
(0.3*0.2cm)  
No change 
(0.3*0.2cm) 
Mild 
reduction 
(0.25*0.1 cm) 
Considerable 
Reduction 
(0.2*0.1 cm) 
Base is almost 
absent 
- 
Shedding of 
hyper 
keratinised 
tissue 
Absent Absent 
Started 
shedding 
from 
periphery. 
All outer 
tissues shed 
off. 
Complete shed 
off of hyper 
keratinised 
tissues with 
centre 
thickening 
No visible 
hyper 
kratinisation 
or thickness. 
 
Scar 
- - 
Poor scar 
with hard 
and 
thickened 
base 
Moderate 
visible scar 
with thickened 
peripheral skin 
Good and 
acceptable scar 
with  almost 
normal skin 
Scar  
replaced 
with normal 
skin 
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Table 4: Observations on subjective features 
Assessment 
features 
Days of assessment with observations 
 12.06.2019 14.06.2019 16.06.2019 18.06.2019 23.06.2019 28.06.2019 
Pain Mild (during injection) Mild  Absent Absent Absent Absent 
Burning 
sensation 
Mild (during injection) Absent Absent Absent Absent Absent 
itching Absent Absent Absent Absent Absent Absent 
Hardness  Present  Present Present at 
border 
Absent Absent Absent 
Discussion 
Pratisaraneeya kshara being the drug of 
choice in different Adhimamsa vikaras and can cure 
diseases of Kaphaja, Medaja and Mamsaja origin 
with its potent action, thus it has a very significant 
action on the resolution of Charmakeela. Compared 
with topical drug application, in Pratisaraneeya 
kshara karama when Kshara use as subcutaneous 
intralesional injection, the drug penetration can be 
maximum. The resistance provided by the stratum 
basalis layer of skin prevent the reach of drugs to 
deeper tissues in topical drug application. This is 
almost absent in injection method. The drug 
directly cross the basalis layer and reach the 
subcutaneous where the base of wart is seated. 
Subcutaneous injection is also found as one among 
the safe, reliable and less invasive route of medicine 
administration beneath the epidermis where blood 
flow is very much limited results in slow absorption 
of drug10. 
The Teekshna kshara used in the present 
case facilitates the action through its strong 
potency. Immediate diffusion of the drug takes 
place to provide the concerned effect. Kshara is 
found to have Ksharana (cutting and scraping of 
unwanted tissue) and Kshanana (debridement of 
necrosed tissue) properties respectively.[11] This can 
also promotes the action of shedding of the lesion. 
Kshara also have Chedya (excising), Bhedya 
(cutting) and Darana (bursting) properties, these 
may help to remove the unwanted tissues from 
body surfaces and support debridement action. The 
Ushana (producing heat) and Theekshna 
(penetrating deep) Gunas (qualities) of Kshara may 
Works on Pachana (ripening) of Keelavat 
maamsangura (nail like fleshy sprouts) and may 
dissolves it by Vilayana (liquefaction) property. 
Theekshna Kshara (alkali of strong potency) may 
dissolves the bonding of Vata and Kapha through 
the process of Vilayana. It can be correlate with the 
lysis of hyperkeratinised lesion- the process of 
protein lysis. [11] 
Aragwadha theekshna kshara consists of five 
drugs, taking its Rasadi properties into 
consideration it is again found to support caustic 
nature of Kshara & excision of warts. [12] 
Rasa: Citraka, Langali and Vaca–katu (pungent) & 
Aragwadha–Madhura (sweet) 
Guna: Laghu (light) and Theekshna (penetrating) 
Veerya: Ushna (hot potency) 
Vipaka: Katu (pungent) 
Minimum scar formation is one of the other 
observed feature in this procedure. The Soumya 
kshara guna (cooling quality) can be the factor 
which aids in healthy epithelialisation and normal 
skin formation. As a whole, the case study shows 
primacy over existing conventional management of 
warts through the observations made. 
CONCLUSION 
There exist a number of treatment 
modalities for curing Charmakeela. Most of the 
classical methods need multiple sitting and is time 
consuming. The present case study shows a 
complete halt to these issues. The subcutaneous 
intralesional injection procedure is observed as a 
treatment with minimum time conception and 
maximum cost effectiveness. Ulceration followed by 
primary management of wart is the other common 
complication arising in wart treatment. It give rise 
the need of following wound treatment in most of 
the cases. But in Kshara karma as subcutaneous 
intralesional injection, no visible stages of 
transformation in the wound healing phase over the 
external skin surface is noted. The stage of mild 
inflammation to the stage of granulation tissue 
formation and re-epithelialisation was found to 
taking place under the hyper granulated tissues. 
Also there is minimum scaring of the wart site with 
healthy epithelialisation and formation of normal 
skin observed by the end of seventeen days. Pain, 
itching and other complications were also nil. This 
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points that significant effect of subcutaneous 
intralesional injection of Aragwadhaksharodhaka. 
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